Palau

Palau

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
4.32 (3.64 - 5.02) 2019 Modelled IHME
4.61 (3.86 - 5.27) 2018 Modelled IHME
4.74 (3.95 - 5.54) 2017 Modelled IHME
4.73 (3.95 - 5.56) 2016 Modelled IHME
4.71 (3.91 - 5.66) 2015 Modelled IHME
4.71 (3.94 - 5.59) 2014 Modelled IHME
4.71 (3.93 - 5.55) 2013 Modelled IHME
4.72 (3.92 - 5.56) 2012 Modelled IHME
4.73 (3.92 - 5.57) 2011 Modelled IHME
4.75 (3.89 - 5.56) 2010 Modelled IHME
4.81 (3.95 - 5.61) 2009 Modelled IHME
4.95 (4.08 - 5.74) 2008 Modelled IHME
5.11 (4.22 - 5.92) 2007 Modelled IHME
5.24 (4.32 - 6.10) 2006 Modelled IHME
5.3 (4.33 - 6.25) 2005 Modelled IHME
5.3 (4.37 - 6.22) 2004 Modelled IHME
5.29 (4.36 - 6.26) 2003 Modelled IHME
5.28 (4.32 - 6.22) 2002 Modelled IHME
5.27 (4.25 - 6.25) 2001 Modelled IHME
5.27 (4.18 - 6.32) 2000 Modelled IHME
5.31 (4.27 - 6.36) 1999 Modelled IHME
5.41 (4.40 - 6.52) 1998 Modelled IHME
5.54 (4.50 - 6.63) 1997 Modelled IHME
5.65 (4.57 - 6.78) 1996 Modelled IHME
5.73 (4.61 - 6.95) 1995 Modelled IHME
5.78 (4.60 - 6.94) 1994 Modelled IHME
5.82 (4.60 - 6.98) 1993 Modelled IHME
5.86 (4.57 - 7.02) 1992 Modelled IHME
5.88 (4.51 - 7.07) 1991 Modelled IHME
5.9 (4.40 - 7.15) 1990 Modelled IHME
1.38 (0.09 - 19.69) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.49 (0.33 - 0.65) 2019 Modelled IHME
0.55 (0.37 - 0.73) 2018 Modelled IHME
0.6 (0.40 - 0.80) 2017 Modelled IHME
0.63 (0.42 - 0.85) 2016 Modelled IHME
0.67 (0.43 - 0.91) 2015 Modelled IHME
0.71 (0.46 - 0.98) 2014 Modelled IHME
0.77 (0.49 - 1.07) 2013 Modelled IHME
0.83 (0.53 - 1.15) 2012 Modelled IHME
0.87 (0.56 - 1.21) 2011 Modelled IHME
0.89 (0.57 - 1.25) 2010 Modelled IHME
0.84 (0.55 - 1.18) 2009 Modelled IHME
0.73 (0.47 - 1.01) 2008 Modelled IHME
0.59 (0.38 - 0.81) 2007 Modelled IHME
0.47 (0.31 - 0.65) 2006 Modelled IHME
0.42 (0.28 - 0.58) 2005 Modelled IHME
0.42 (0.28 - 0.58) 2004 Modelled IHME
0.42 (0.27 - 0.57) 2003 Modelled IHME
0.43 (0.27 - 0.57) 2002 Modelled IHME
0.43 (0.27 - 0.58) 2001 Modelled IHME
0.43 (0.27 - 0.58) 2000 Modelled IHME
0.45 (0.28 - 0.60) 1999 Modelled IHME
0.49 (0.31 - 0.66) 1998 Modelled IHME
0.55 (0.35 - 0.75) 1997 Modelled IHME
0.61 (0.39 - 0.85) 1996 Modelled IHME
0.68 (0.43 - 0.95) 1995 Modelled IHME
0.74 (0.47 - 1.04) 1994 Modelled IHME
0.82 (0.52 - 1.13) 1993 Modelled IHME
0.9 (0.56 - 1.24) 1992 Modelled IHME
0.99 (0.61 - 1.36) 1991 Modelled IHME
1.08 (0.66 - 1.48) 1990 Modelled IHME
0.21 (0.01 - 3.83) 2015 Modelled WHO
0 2008 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
908 (677 - 1,102) 1990 Modelled IHME
930 (714 - 1,118) 1991 Modelled IHME
952 (742 - 1,142) 1992 Modelled IHME
973 (769 - 1,168) 1993 Modelled IHME
994 (791 - 1,194) 1994 Modelled IHME
1,014 (815 - 1,229) 1995 Modelled IHME
1,028 (831 - 1,233) 1996 Modelled IHME
1,033 (840 - 1,236) 1997 Modelled IHME
1,034 (841 - 1,246) 1998 Modelled IHME
1,038 (835 - 1,243) 1999 Modelled IHME
1,049 (832 - 1,258) 2000 Modelled IHME
1,065 (858 - 1,264) 2001 Modelled IHME
1,077 (882 - 1,268) 2002 Modelled IHME
1,085 (894 - 1,283) 2003 Modelled IHME
1,086 (894 - 1,273) 2004 Modelled IHME
1,079 (881 - 1,271) 2005 Modelled IHME
1,053 (868 - 1,224) 2006 Modelled IHME
1,007 (832 - 1,166) 2007 Modelled IHME
955 (787 - 1,107) 2008 Modelled IHME
908 (745 - 1,058) 2009 Modelled IHME
876 (719 - 1,027) 2010 Modelled IHME
859 (711 - 1,011) 2011 Modelled IHME
846 (702 - 998) 2012 Modelled IHME
841 (701 - 990) 2013 Modelled IHME
841 (703 - 999) 2014 Modelled IHME
843 (701 - 1,013) 2015 Modelled IHME
848 (708 - 997) 2016 Modelled IHME
852 (710 - 995) 2017 Modelled IHME
829 (695 - 949) 2018 Modelled IHME
778 (656 - 905) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
15.3 (10.60 - 21.40) 2019 Modelled IHME
14.7 (10.30 - 20.50) 2018 Modelled IHME
14.3 (10 - 19.90) 2017 Modelled IHME
13.7 (9.63 - 19.10) 2016 Modelled IHME
13.3 (9.31 - 18.50) 2015 Modelled IHME
13 (9.07 - 18.20) 2014 Modelled IHME
12.6 (8.82 - 18) 2013 Modelled IHME
12.4 (8.63 - 17.50) 2012 Modelled IHME
12.1 (8.49 - 17) 2011 Modelled IHME
11.9 (8.32 - 16.60) 2010 Modelled IHME
11.6 (8.15 - 16.20) 2009 Modelled IHME
11.4 (8.02 - 15.90) 2008 Modelled IHME
11.3 (7.81 - 15.60) 2007 Modelled IHME
11.1 (7.80 - 15.40) 2006 Modelled IHME
11.1 (7.78 - 15.30) 2005 Modelled IHME
10.9 (7.61 - 15.20) 2004 Modelled IHME
10.9 (7.62 - 15.10) 2003 Modelled IHME
10.9 (7.56 - 15.20) 2002 Modelled IHME
10.9 (7.53 - 15.20) 2001 Modelled IHME
10.9 (7.44 - 15.10) 2000 Modelled IHME
10.9 (7.37 - 15.20) 1999 Modelled IHME
10.9 (7.37 - 15.30) 1998 Modelled IHME
11.1 (7.43 - 15.50) 1997 Modelled IHME
11.2 (7.52 - 15.80) 1996 Modelled IHME
11.2 (7.60 - 15.80) 1995 Modelled IHME
11.1 (7.49 - 15.60) 1994 Modelled IHME
11.2 (7.64 - 15.50) 1993 Modelled IHME
11.1 (7.64 - 15.40) 1992 Modelled IHME
11.2 (7.67 - 15.60) 1991 Modelled IHME
11.2 (7.72 - 15.60) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
3 (2 - 4) 2019 Modelled IHME
3 (2 - 4) 2018 Modelled IHME
3 (2 - 4) 2017 Modelled IHME
2 (2 - 3) 2016 Modelled IHME
2 (2 - 3) 2015 Modelled IHME
2 (2 - 3) 2014 Modelled IHME
2 (2 - 3) 2013 Modelled IHME
2 (2 - 3) 2012 Modelled IHME
2 (2 - 3) 2011 Modelled IHME
2 (2 - 3) 2010 Modelled IHME
2 (2 - 3) 2009 Modelled IHME
2 (2 - 3) 2008 Modelled IHME
2 (2 - 3) 2007 Modelled IHME
2 (2 - 3) 2006 Modelled IHME
2 (2 - 3) 2005 Modelled IHME
2 (2 - 3) 2004 Modelled IHME
2 (2 - 3) 2003 Modelled IHME
2 (2 - 3) 2002 Modelled IHME
2 (2 - 3) 2001 Modelled IHME
2 (1 - 3) 2000 Modelled IHME
2 (1 - 3) 1999 Modelled IHME
2 (1 - 3) 1998 Modelled IHME
2 (1 - 3) 1997 Modelled IHME
2 (1 - 3) 1996 Modelled IHME
2 (1 - 3) 1995 Modelled IHME
2 (1 - 3) 1994 Modelled IHME
2 (1 - 3) 1993 Modelled IHME
2 (1 - 3) 1992 Modelled IHME
2 (1 - 2) 1991 Modelled IHME
2 (1 - 2) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
61 (52 - 69) 2019 Modelled IHME
61 (51 - 70) 2018 Modelled IHME
61 (51 - 70) 2017 Modelled IHME
61 (52 - 70) 2016 Modelled IHME
61 (52 - 70) 2015 Modelled IHME
61 (52 - 70) 2014 Modelled IHME
61 (52 - 70) 2013 Modelled IHME
61 (52 - 70) 2012 Modelled IHME
61 (52 - 70) 2011 Modelled IHME
61 (52 - 70) 2010 Modelled IHME
61 (53 - 70) 2009 Modelled IHME
62 (53 - 70) 2008 Modelled IHME
62 (54 - 70) 2007 Modelled IHME
62 (54 - 71) 2006 Modelled IHME
62 (54 - 71) 2005 Modelled IHME
62 (54 - 71) 2004 Modelled IHME
62 (54 - 71) 2003 Modelled IHME
62 (54 - 71) 2002 Modelled IHME
62 (54 - 71) 2001 Modelled IHME
62 (54 - 71) 2000 Modelled IHME
62 (54 - 70) 1999 Modelled IHME
62 (54 - 71) 1998 Modelled IHME
63 (54 - 71) 1997 Modelled IHME
63 (54 - 71) 1996 Modelled IHME
63 (54 - 71) 1995 Modelled IHME
62 (54 - 71) 1994 Modelled IHME
62 (54 - 71) 1993 Modelled IHME
62 (53 - 70) 1992 Modelled IHME
62 (53 - 70) 1991 Modelled IHME
62 (53 - 70) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
67 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
90 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
89 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
80 2010 Survey/reported WHO/UNICEF
69 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
91 2007 Survey/reported WHO/UNICEF
98 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
98 2001 Survey/reported WHO/UNICEF
96 2000 Survey/reported WHO/UNICEF
96 1999 Survey/reported WHO/UNICEF
96 1998 Survey/reported WHO/UNICEF
90 1997 Survey/reported WHO/UNICEF
99 1996 Survey/reported WHO/UNICEF
99 1995 Survey/reported WHO/UNICEF
73 1994 Survey/reported WHO/UNICEF
94 1993 Survey/reported WHO/UNICEF
75 1992 Survey/reported WHO/UNICEF
89 1991 Survey/reported WHO/UNICEF
98 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2009
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.56 (0.45 - 0.69) 2019 Modelled IHME
0.56 (0.44 - 0.69) 2018 Modelled IHME
0.55 (0.44 - 0.68) 2017 Modelled IHME
0.55 (0.44 - 0.68) 2016 Modelled IHME
0.55 (0.44 - 0.68) 2015 Modelled IHME
0.55 (0.44 - 0.67) 2014 Modelled IHME
0.55 (0.44 - 0.67) 2013 Modelled IHME
0.55 (0.44 - 0.67) 2012 Modelled IHME
0.55 (0.44 - 0.67) 2011 Modelled IHME
0.55 (0.44 - 0.68) 2010 Modelled IHME
0.54 (0.43 - 0.67) 2009 Modelled IHME
0.54 (0.43 - 0.67) 2008 Modelled IHME
0.54 (0.43 - 0.67) 2007 Modelled IHME
0.54 (0.43 - 0.66) 2006 Modelled IHME
0.54 (0.43 - 0.66) 2005 Modelled IHME
0.54 (0.42 - 0.66) 2004 Modelled IHME
0.53 (0.43 - 0.66) 2003 Modelled IHME
0.53 (0.42 - 0.66) 2002 Modelled IHME
0.53 (0.42 - 0.66) 2001 Modelled IHME
0.53 (0.42 - 0.66) 2000 Modelled IHME
0.53 (0.42 - 0.65) 1999 Modelled IHME
0.53 (0.42 - 0.65) 1998 Modelled IHME
0.53 (0.42 - 0.65) 1997 Modelled IHME
0.53 (0.42 - 0.65) 1996 Modelled IHME
0.53 (0.42 - 0.65) 1995 Modelled IHME
0.52 (0.42 - 0.64) 1994 Modelled IHME
0.52 (0.41 - 0.64) 1993 Modelled IHME
0.52 (0.41 - 0.64) 1992 Modelled IHME
0.52 (0.41 - 0.64) 1991 Modelled IHME
0.52 (0.41 - 0.64) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
79 (63 - 99) 1990 Modelled IHME
82 (65 - 101) 1991 Modelled IHME
85 (67 - 104) 1992 Modelled IHME
87 (69 - 108) 1993 Modelled IHME
90 (71 - 111) 1994 Modelled IHME
93 (74 - 115) 1995 Modelled IHME
96 (76 - 118) 1996 Modelled IHME
98 (78 - 121) 1997 Modelled IHME
101 (81 - 125) 1998 Modelled IHME
103 (82 - 128) 1999 Modelled IHME
105 (83 - 131) 2000 Modelled IHME
107 (85 - 132) 2001 Modelled IHME
109 (86 - 134) 2002 Modelled IHME
109 (87 - 135) 2003 Modelled IHME
110 (87 - 135) 2004 Modelled IHME
109 (87 - 135) 2005 Modelled IHME
108 (86 - 133) 2006 Modelled IHME
107 (85 - 131) 2007 Modelled IHME
105 (83 - 129) 2008 Modelled IHME
103 (81 - 127) 2009 Modelled IHME
101 (80 - 125) 2010 Modelled IHME
99 (79 - 122) 2011 Modelled IHME
98 (78 - 120) 2012 Modelled IHME
97 (79 - 120) 2013 Modelled IHME
98 (78 - 120) 2014 Modelled IHME
98 (79 - 121) 2015 Modelled IHME
99 (79 - 121) 2016 Modelled IHME
99 (80 - 123) 2017 Modelled IHME
100 (80 - 124) 2018 Modelled IHME
101 (81 - 125) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.01 (4.29 - 11) 2019 Modelled IHME
6.91 (4.26 - 10.70) 2018 Modelled IHME
6.83 (4.22 - 10.60) 2017 Modelled IHME
6.77 (4.18 - 10.60) 2016 Modelled IHME
6.69 (4.08 - 10.40) 2015 Modelled IHME
6.56 (4.01 - 10.20) 2014 Modelled IHME
6.41 (3.91 - 9.91) 2013 Modelled IHME
6.27 (3.82 - 9.73) 2012 Modelled IHME
6.16 (3.77 - 9.57) 2011 Modelled IHME
6.04 (3.71 - 9.40) 2010 Modelled IHME
5.91 (3.67 - 9.13) 2009 Modelled IHME
5.77 (3.57 - 9) 2008 Modelled IHME
5.66 (3.49 - 8.70) 2007 Modelled IHME
5.57 (3.42 - 8.63) 2006 Modelled IHME
5.49 (3.36 - 8.49) 2005 Modelled IHME
5.41 (3.31 - 8.30) 2004 Modelled IHME
5.37 (3.28 - 8.32) 2003 Modelled IHME
5.36 (3.28 - 8.37) 2002 Modelled IHME
5.36 (3.27 - 8.42) 2001 Modelled IHME
5.34 (3.25 - 8.37) 2000 Modelled IHME
5.21 (3.14 - 8.19) 1999 Modelled IHME
4.98 (2.99 - 7.80) 1998 Modelled IHME
4.78 (2.86 - 7.48) 1997 Modelled IHME
4.62 (2.74 - 7.15) 1996 Modelled IHME
4.54 (2.69 - 7.09) 1995 Modelled IHME
4.49 (2.64 - 7.06) 1994 Modelled IHME
4.5 (2.67 - 7.03) 1993 Modelled IHME
4.49 (2.66 - 7.07) 1992 Modelled IHME
4.51 (2.67 - 7.07) 1991 Modelled IHME
4.55 (2.69 - 7.06) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
1 (1 - 2) 2019 Modelled IHME
1 (1 - 2) 2018 Modelled IHME
1 (1 - 2) 2017 Modelled IHME
1 (1 - 2) 2016 Modelled IHME
1 (1 - 2) 2015 Modelled IHME
1 (1 - 2) 2014 Modelled IHME
1 (1 - 2) 2013 Modelled IHME
1 (1 - 2) 2012 Modelled IHME
1 (1 - 2) 2011 Modelled IHME
1 (1 - 2) 2010 Modelled IHME
1 (1 - 2) 2009 Modelled IHME
1 (1 - 2) 2008 Modelled IHME
1 (1 - 2) 2007 Modelled IHME
1 (1 - 2) 2006 Modelled IHME
1 (1 - 2) 2005 Modelled IHME
1 (1 - 2) 2004 Modelled IHME
1 (1 - 2) 2003 Modelled IHME
1 (1 - 2) 2002 Modelled IHME
1 (1 - 2) 2001 Modelled IHME
1 (1 - 2) 2000 Modelled IHME
1 (1 - 2) 1999 Modelled IHME
1 (1 - 1) 1998 Modelled IHME
1 (1 - 1) 1997 Modelled IHME
1 (1 - 1) 1996 Modelled IHME
1 (0 - 1) 1995 Modelled IHME
1 (0 - 1) 1994 Modelled IHME
1 (0 - 1) 1993 Modelled IHME
1 (0 - 1) 1992 Modelled IHME
1 (0 - 1) 1991 Modelled IHME
1 (0 - 1) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
15 (10 - 21) 2019 Modelled IHME
14 (9 - 20) 2018 Modelled IHME
14 (9 - 20) 2017 Modelled IHME
14 (10 - 20) 2016 Modelled IHME
15 (10 - 20) 2015 Modelled IHME
15 (10 - 20) 2014 Modelled IHME
15 (10 - 20) 2013 Modelled IHME
15 (10 - 20) 2012 Modelled IHME
14 (10 - 20) 2011 Modelled IHME
14 (10 - 20) 2010 Modelled IHME
14 (10 - 20) 2009 Modelled IHME
14 (9 - 20) 2008 Modelled IHME
14 (9 - 19) 2007 Modelled IHME
14 (9 - 19) 2006 Modelled IHME
14 (9 - 19) 2005 Modelled IHME
14 (9 - 19) 2004 Modelled IHME
14 (9 - 19) 2003 Modelled IHME
14 (9 - 19) 2002 Modelled IHME
14 (9 - 19) 2001 Modelled IHME
14 (9 - 19) 2000 Modelled IHME
14 (9 - 20) 1999 Modelled IHME
14 (10 - 20) 1998 Modelled IHME
14 (10 - 20) 1997 Modelled IHME
14 (10 - 20) 1996 Modelled IHME
15 (10 - 21) 1995 Modelled IHME
15 (10 - 21) 1994 Modelled IHME
15 (10 - 21) 1993 Modelled IHME
15 (10 - 21) 1992 Modelled IHME
15 (10 - 21) 1991 Modelled IHME
15 (10 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2009
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
3
2019
(2 - 4)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1
2019
(1 - 2)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners